Tag: argos therapeutics

February 15, 2018

Argos Announces Issuance of Patent Covering the Foundation for Manufacturing its HIV Immunotherapy

Argos Therapeutics (NASDAQ:ARGS), an immuno-oncology company focused on the development and commercialization of individualized immunotherapies based on the Arcelis® precision immunotherapy...
February 5, 2018

Argos Obtains Option to License PD1 Checkpoint Inhibitors

Argos Therapeutics (NASDAQ:ARGS), an immuno-oncology company focused on the development and commercialization of individualized immunotherapies based on the Arcelis® precision...
January 18, 2018

Argos Announces One-for-Twenty Reverse Stock Split

Argos Therapeutics (NASDAQ:ARGS) an immuno-oncology company focused on the development and commercialization of individualized immunotherapies based on the Arcelis® precision...